Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mm_liver_organelle-pre5_6

ABSTRACT: Mouse Liver Organelle pre5_6

INSTRUMENT(S): LTQ

ORGANISM(S): Mus Musculus

SUBMITTER: DMartin

PROVIDER: PAe000417 | PeptideAtlas |

REPOSITORIES: PeptideAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PAe000417_4961_search.params.tar.gz	Other
	PAe000417_4961_searchdatabase_tandem.fasta	Fasta
	PAe000417_4961_tandem.params	Other
	PAe000417_RAW_201104191341.tar.gz	Other
	PAe000417_README	Other

Items per page:

1 - 5 of 11

Similar Datasets

mm_liver_organelle

Project description:Mouse Liver Organelle

| PAe000288 | PeptideAtlas

mm_liver_organelle-25_1

Project description:Mouse Liver Organelle 25_1

| PAe000309 | PeptideAtlas

mm_liver_organelle-pre7

Project description:Mouse Liver Organelle pre7

| PAe000306 | PeptideAtlas

mm_liver_organelle-20_9-10

Project description:Mouse Liver Organelle 20_9-10

| PAe000308 | PeptideAtlas

Peroxisomes and mitochondria are dysfunctional in obese diabetic (db/db) mice with fatty liver

Project description:Major causes of lipid accumulation in liver are increased import, synthesis or decreased catabolism of fatty acids. The latter is caused by dysfunction of cellular organelle controlling energy homeostasis, i.e. mitochondria. However, peroxisomes appear to be an important organelle in lipid metabolism of hepatocytes, but little is known about their role in the development of non-alcoholic fatty liver disease (NAFLD). To investigate the role of peroxisomes next to mitochondria in excessive hepatic lipid accumulation we used the leptin resistant db/db mice on C57BLKS background, a mouse model that develops hyperphagia induced diabetes with obesity and NAFLD. We used microarrays to determine differences in hepatic gene expression in a mouse model for NAFDL (BKS.Cg-Leprdb (db/db)) and their wildtype littermates C57BL/KSlepr+/+ (BKS) to determine the effect of persistent hepatic lipid accumulation.

2015-03-23 | GSE59930 | GEO

Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

Project description:Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

| PRJNA1257843 | ENA

Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

Project description:Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

| PRJNA1257844 | ENA

Mitochondria-rough-ER Contacts in The Liver Regulate Systemic Lipid Homeostasis

Project description:Contacts between organelles create microdomains that play major roles in regulating key intracellular activities and signaling pathways, but whether they also directly regulate systemic cellular activities, remains unknown. Here, we report the ultrastructural organization and dynamics of a new type of inter-organelle contact which is formed by rough-Endoplasmic Reticulum that is closely wrapped around the mitochondrion (wrappER). To elucidate the in vivo function of this inter-organelle association, mouse liver fractions enriched in wrappER-associated-mitochondria were analyzed in parallel by transcriptomics, proteomics, and lipidomics. The biochemical signature of the wrappER points to an unexpected role in the biogenesis of very-low-density lipoproteins (VLDLs). Altering wrappER-mitochondria contacts curtails liver VLDL secretion and increases hepatic fatty acids, lipid droplets and neutral lipid content. Conversely, acute liver-specific ablation of Mttp, the most upstream regulator of VLDL biogenesis, mirrors this hepatic dyslipidemia phenotype and promotes remodelling of the wrappER-mitochondria contact. The participation of liver wrappER-mitochondria contacts in VLDL biology reveals a role of inter-organelle contacts in systemic lipid homeostasis.

2021-03-15 | PXD021826 | Pride

Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

Project description:Dynamin-related protein 1 (Drp1) plays a critical role in mitochondrial fission and liver function. The interactions between mitochondria, endoplasmic reticulum (ER), and lipid droplets (LDs) are essential for lipid metabolism. In this study, liver-specific Drp1 knockout (Drp1LiKO) mice were utilized to investigate the impact of disrupted organelle interactions. Analysis revealed increased interactions between mitochondria and LDs, as well as among ER, mitochondria, and LDs in Drp1LiKO mice. As a result, impaired fatty acid metabolism was observed, leading to liver inflammation. In vitro studies using primary hepatocytes from Drp1LiKO mice further confirmed disrupted lipid metabolism and increased inflammation. These findings underscore the significance of Drp1 in maintaining organelle interactions for proper lipid metabolism and liver health. Tar-geting Drp1-mediated interactions may present a promising approach for the treatment of liver diseases associated with lipid metabolism dysregulation.

2025-05-01 | GSE296128 | GEO

Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver

Project description:Dynamin-related protein 1 (Drp1) plays a critical role in mitochondrial fission and liver function. The interactions between mitochondria, endoplasmic reticulum (ER), and lipid droplets (LDs) are essential for lipid metabolism. In this study, liver-specific Drp1 knockout (Drp1LiKO) mice were utilized to investigate the impact of disrupted organelle interactions. Analysis revealed increased interactions between mitochondria and LDs, as well as among ER, mitochondria, and LDs in Drp1LiKO mice. As a result, impaired fatty acid metabolism was observed, leading to liver inflammation. In vitro studies using primary hepatocytes from Drp1LiKO mice further confirmed disrupted lipid metabolism and increased inflammation. These findings underscore the significance of Drp1 in maintaining organelle interactions for proper lipid metabolism and liver health. Targeting Drp1-mediated interactions may present a promising approach for the treatment of liver diseases associated with lipid metabolism dysregulation.

2025-05-01 | GSE296127 | GEO